Figure 5
From: Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma
A Kaplan–Meier curve estimates the association of miRNAs and the survival of patients with stage II/III colorectal cancer who received adjuvant chemotherapy.
(A) Association between the expression of miR-17-3p and miR-106a and disease-free survival (DFS) in patients with stage II/III CRC who had received chemotherapy. (B) Associations between the expression of miR-17-3p and miR-106a and DFS in patients with stage II CRC who had received chemotherapy. (C) Association between the expression of miR-17-3p and miR-106a and DFS among patients with stage III CRC who had received chemotherapy.
